Cargando…
SAT649 Org43553, The First Low-molecular-weight Agonist Of The Human Luteinizing Hormone Receptor Induces Leanness And Energy Expenditure In Mice
Disclosure: D. Lizneva: None. A. Gumerova: None. K. Ievleva: None. O. Barak: None. F. Korkmaz: None. J. Gimenez Roig: None. T. Frolinger: None. G. Pevnev: None. F. Sultana: None. N. Kramskiy: None. S. Wizman: None. M. Orloff: None. A.R. Pallapati: None. S. Rojekar: None. V. Ryu: None. O. Moldavski:...
Autores principales: | Lizneva, Daria, Gumerova, Anisa, Ievleva, Kseniia, Barak, Orly, Korkmaz, Funda, Roig, Judit Gimenez, Frolinger, Tal, Pevnev, Georgii, Sultana, Farhath, Kramskiy, Natan, Wizman, Soleil, Orloff, Michelle, Pallapati, Anusha Rani, Rojekar, Satish, Ryu, Vitaly, Moldavski, Ofer, Yuen, Tony, Zaidi, Mone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553952/ http://dx.doi.org/10.1210/jendso/bvad114.097 |
Ejemplares similares
-
RF10 | PMON205 LH/CG Receptor Activation Protects Mice from Diet-Induced Obesity and Modifies Adipose Tissue Immune Response
por: Lizneva, Daria, et al.
Publicado: (2022) -
SAT669 Development And Biophysical Characterization Of A Humanized FSH-blocking Monoclonal Antibody Therapeutic Formulated At An Ultra-high Concentration
por: Rojekar, Satish, et al.
Publicado: (2023) -
OR27-05 Two-pronged Mediation Of Adrenal Steroidogenesis By Oxytocin
por: Cheliadinova, Uliana, et al.
Publicado: (2023) -
SAT668 Can We Treat Osteoporosis, Obesity And Neurodegeneration With A Single FSH-blocking Drug?
por: Rani Pallapati, Anusha Rani, et al.
Publicado: (2023) -
FRI001 Tanycytic Thyroid-stimulating Hormone Receptor Activation Increases Blood-Hypothalamus Barrier Permeability And Induces Appetite In Female Mice
por: Kannangara, Hasni Suhasha, et al.
Publicado: (2023)